Rapport Therapeutics, Inc. Common Stock (RAPP)

18.83

(-1.26%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022
Total Assets 155.42 Million 31.6 Million
Total Current Assets 150.87 Million 31.26 Million
Cash And Short Term Investments 147.56 Million 31.15 Million
Cash and Cash Equivalents 70.25 Million 31.15 Million
Short Term Investments 77.3 Million -
Net Receivables - -
Inventory - -
Other Current Assets 3.3 Million 109 Thousand
Total Non-Current Assets 4.55 Million 335 Thousand
Net PPE 4 Million 335 Thousand
Good Will And Intangible Assets - -
Good Will - -
Intangible Assets - -
Long-Term Investments - -
Tax Assets - -
Other Non Current Assets 550.99 Thousand -
Other Assets 1.00 -
Total Liabilities 14.47 Million 12.09 Million
Total Current Liabilities 8.8 Million 1.66 Million
Account Payables 2.5 Million 1.45 Million
Tax Payables - -
Short Term Debt 670 Thousand -
Deferred Revenue -2.5 Million -
Other Current Liabilities 8.13 Million 213 Thousand
Total Non Current Liabilities 5.67 Million 10.43 Million
Long-Term Debt 1.47 Million -
Deferred Revenue Non Current - -
Deferred Tax Liabilities Non Current - -
Other Non Current Liabilities 4.19 Million 10.43 Million
Other Liabilities 1.00 -
Total Equity 140.94 Million 19.5 Million
Stock Holders Equity 140.94 Million 19.5 Million
Common Stock 36 Thousand 31 Thousand
Retained Earnings -45.43 Million -10.65 Million
Accumulated other comprehensive income 4000.00 -31 Thousand
Common Stock Equity 140.94 Million 19.5 Million
Capital Lease Obligation 1.47 Million -
Total Investments 77.3 Million -
Total Debt 2.14 Million -
Net Debt -68.1 Million -31.15 Million

Balance Sheet Charts